Global Stem Cell Banking Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Stem Cell Banking Market is presumed to reach the market size of nearly USD 19.49 Billion by 2032 from USD 8.9 Billion in 2023 with a CAGR of 9.1% under the study period 2024-2032.

Stem cell banking is the process involving the preservation of stem cells that are extracted from the placenta, umbilical cord and cord tissue at extremely low temperature for a long time period. These cells are storedfor its use in regenerative medicine for repairing damaged tissue, organs, transplanting& treating different diseases. Stem cell banking includes collecting, processing and preserving the stem cells with possess ability to develop different blood and tissue cells.

MARKET DYNAMICS

The stem cell banking market is experiencing growth since past few years owing to rise in prevalence of chronic medical condition. Stem Cell therapy possess high potential in treating range of fatal and chronic medical conditions. Hike in prevalence of kidney diseases, lungs diseases, diabetes, and others, is driving demand for stem cell therapy. Increasing awareness regarding the benefits of stem cell therapy is resulting into higher investment towards pushing the Stem Cell-Based Research. On the contrary side, strict regulation imposed by the FDA on stem cell therapy with high operational cost associated with stem cell banking is hampering the growth of the market

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Stem Cell Banking. The growth and trends of Stem Cell Banking industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Stem Cell Banking market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Source

Placental Stem Cells (PSCS)
Adipose Tissue-derived Stem Cells (ADSCS)
Bone Marrow-derived Stem Cells (BMSCS)
Human Embryo-derived Stem Cells (HESCS)
Dental Pulp-derived Stem Cells (DPSCS)
Other

By Service Type

Sample Preservation & Storage
Sample Analysis
Sample Processing
Sample Collection & Transportation

By Application

Personalized Banking Applications
Research Applications (Disease Treatment Studies, Life Science Research, Drug Discovery)
Clinical Application (Hematopoietic Disorders, Autoimmune Disorders, Other)

By End-user

Hospitals
Specialty Clinics
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Stem Cell Banking market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Stem Cell Banking market include Cord Blood Registry (CBR) Systems, Cordlife Group Limited, Cryo-Cell International, ViaCord, LifeCell International, StemCyte, Global Cord Blood Corporation, Smart Cells International, Vita34 AG, CryoHoldco (Mexico). This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11211839

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. STEM CELL BANKING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Source
- 3.7.2 Market Attractiveness Analysis By Service Type
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By End-user
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY SOURCE

5.1. Overview By Source
5.2. Historical and Forecast Data
5.3. Analysis By Source
5.4. Placental Stem Cells (PSCS) Historic and Forecast Sales By Regions
5.5. Adipose Tissue-derived Stem Cells (ADSCS) Historic and Forecast Sales By Regions
5.6. Bone Marrow-derived Stem Cells (BMSCS) Historic and Forecast Sales By Regions
5.7. Human Embryo-derived Stem Cells (HESCS) Historic and Forecast Sales By Regions
5.8. Dental Pulp-derived Stem Cells (DPSCS) Historic and Forecast Sales By Regions
5.9. Other Historic and Forecast Sales By Regions

6. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY SERVICE TYPE

6.1. Overview By Service Type
6.2. Historical and Forecast Data
6.3. Analysis By Service Type
6.4. Sample Preservation & Storage Historic and Forecast Sales By Regions
6.5. Sample Analysis Historic and Forecast Sales By Regions
6.6. Sample Processing Historic and Forecast Sales By Regions
6.7. Sample Collection & Transportation Historic and Forecast Sales By Regions

7. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data
7.3. Analysis By Application
7.4. Personalized Banking Applications Historic and Forecast Sales By Regions
7.5. Research Applications (Disease Treatment Studies, Life Science Research, Drug Discovery) Historic and Forecast Sales By Regions
7.6. Clinical Application (Hematopoietic Disorders, Autoimmune Disorders, Other) Historic and Forecast Sales By Regions

8. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY END-USER

8.1. Overview By End-user
8.2. Historical and Forecast Data
8.3. Analysis By End-user
8.4. Hospitals Historic and Forecast Sales By Regions
8.5. Specialty Clinics Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL STEM CELL BANKING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE STEM CELL BANKING COMPANIES

10.1. Stem Cell Banking Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF STEM CELL BANKING INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Cord Blood Registry (CBR) Systems
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Cordlife Group Limited
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Cryo-Cell International
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. ViaCord
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. LifeCell International
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. StemCyte
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Global Cord Blood Corporation
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Smart Cells International
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Vita34 AG
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. CryoHoldco (Mexico)
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies